News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Oscar Tahuahua: Evidence-Based De-Escalation Is Safe and Effective in Early Breast Cancer
Oscar Tahuahua/X
Jun 28, 2025, 05:01

Oscar Tahuahua: Evidence-Based De-Escalation Is Safe and Effective in Early Breast Cancer

Oscar Tahuahua, Medical Oncology Fellow at the National Cancer Institute of Mexico, shared a post on X about a paper by Icro Meattini et al. published in ASCO Educational Book:

“Multimodal De-Escalation in Early Breast Cancer 2025.
Evidence-based De-escalation is safe and effective; with thoughtful coordination, treatment burden can be reduced without compromising outcomes.”

Title: Multimodal De-Escalation Strategies in Early Breast Cancer

Authors: Icro Meattini, Ana Tecic Vuger, Carlotta Becherini, Eliza J. Epstein, John P. Garcia, Elizabeth R. Berger, Nadia Harbeck.

Oscar Tahuahua: Evidence-Based De-Escalation Is Safe and Effective in Early Breast Cancer

You can read the Full Article in ASCO Educational Book.

More posts featuring Oscar Tahuahua.

Ana Tecic Vuger Breast Cancer cancer Carlotta Becherini Eliza J. Epstein Elizabeth R. Berger Icro Meattini John P. Garcia Nadia Harbeck OncoDaily Oncology Oscar Tahuahua
Special Coverage
Science
Sep 3, 2025, 08:23
Thor Halfdanarson Reflects on New Study About Impact of Therapy on Quality of Life in Patients With NETs
Science
Sep 3, 2025, 08:11
Sanam Loghavi: Cytomolecular Drivers of Relapse After Frontline FLT3 Inhibitor Therapy in FLT3-Mutated AML
Voices
Sep 3, 2025, 08:06
Douglas Flora: What it's Like to Be a Cancer Patient - Leaves, Branches, and Roots
Voices
Sep 3, 2025, 08:01
No Child Left Behind: Prioritizing Childhood Cancer in the Next EU Budget - AIEOP
Voices
Sep 3, 2025, 07:58
Anh Lam: Join us in Chicago for ASCO Quality Care Symposium
Insight
Sep 3, 2025, 07:55
Oncology Updates: August Edition from BG Lab
Science
Sep 3, 2025, 07:49
Alessandro Di Federico: Not All Oncogenes Are the Same
Career Updates
Sep 3, 2025, 07:48
Matthew Kurian: Registration is Open for Implications of HER2 Testing in Cancer Management Session
Voices
Sep 3, 2025, 07:37
Tyler Seibert: Rare but Tragic Outcomes After Radiation for Pelvic Cancers
Societies
Sep 3, 2025, 07:28
Free Childcare for Congress Delegates With Children Aged 1–12 - ESGO
Voices
Sep 3, 2025, 07:14
Eric Whitman: Register for Virtual Post-ASCO Conference on September 20
Science
Sep 3, 2025, 07:05
Jean-Jacques Kiladjian: Pemigatinib for Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement